Who are Metformin plus folic acid's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/metformin-plus-folic-acid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Metformin plus folic acid — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Metformin plus folic acid (Metformin plus folic acid) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antidiabetic agent with vitamin supplement. Area: Endocrinology / Diabetes.

marketed Antidiabetic agent with vitamin supplement AMPK (metformin); folate receptors and methylenetetrahydrofolate reductase (folic acid) Endocrinology / Diabetes Small molecule Live · refreshed every 30 min

Target snapshot

Metformin plus folic acid (Metformin plus folic acid) — University Magna Graecia. Metformin reduces hepatic glucose production and improves insulin sensitivity, while folic acid serves as a methyl donor and cofactor for nucleotide synthesis.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Metformin plus folic acid TARGET	Metformin plus folic acid	University Magna Graecia	marketed	Antidiabetic agent with vitamin supplement	AMPK (metformin); folate receptors and methylenetetrahydrofolate reductase (folic acid)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antidiabetic agent with vitamin supplement class)

University Magna Graecia · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Metformin plus folic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/metformin-plus-folic-acid. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab